Kindred Biosciences reported $46.72M in Cash and Equivalent for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Adma Biologics ADMA:US $ 34.41M 8M
Bayer BAYN:GR € 4316M 927M
Biocryst Pharmaceuticals BCRX:US $ 199.6M 10.72M
Dynavax Technologies DVAX:US $ 246.35M 116.74M
Eli Lilly And LLY:US $ 3788.2M 568.2M
Idexx Laboratories IDXX:US $ 145.2M 86.93M
Jazz Pharmaceuticals JAZZ:US 1000 0
Kindred Biosciences KIN:US $ 46.72M 33.8M
Minerva Neurosciences NERV:US $ 65.59M 8.63M
Novavax NVAX:US $ 366.24M 128.21M
Phibro Animal Health PAHC:US $ 41.18M 9.04M
Zoetis ZTS:US $ 3272M 385M